Results 101 to 110 of about 17,765,664 (260)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Tribute to reviewers

open access: yesWorld Journal of Pediatric Surgery, 2021
Ademola Olusegun Talabi   +5 more
doaj   +1 more source

Ireland's hospitals 1930-1955

open access: yes, 1956
This book details the Irish hospital activities funded by the Hospitals' Trust (1940) Ltd between 1930 and 1955, along with photographs of the hospitals ...
Hospitals' Trust (1940) Ltd
core  

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

American Women's Hospitals Report, 1923

open access: yes, 1923
Dr. Mabel Elliott, a physician with the American Women’s Hospitals reports from Athens, Greece on the services provided to Turkish refugees from the city of Smyrna, following the burning of Smyrna in September ...
Elliott, Mabel Evelyn, b. 1881
core  

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Barbara Stimson to American Women's Hospitals

open access: yes, 1942
Part of letter from Barbara Stimson to American Women's Hospitals, sent by Julia Stimson to Esther ...
Stimson, Barbara B. (Barbara Bartlett), b. 1898
core  

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

American Women's Hospitals 1931 fundraising pamphlet

open access: yes, 1931
American Women's Hospitals fundraising brochure, highlighting their work around the world, including Albania, Greece, and the rural southern United States. Four pages. Illustrated with photographs.
American Women's Hospitals
core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy